Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis.

Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis.

The central nervous system lesions of multiple sclerosis (MS) can be detected by magnetic resonance imaging (MRI) and the initial perivascular inflammatory component is distinguished by the presence of gadolinium enhancement. To assess the effect of systemic lymphocyte depletion on disease activity,...

Detaylı Bibliyografya
Asıl Yazarlar:	Moreau, T, Thorpe, J, Miller, D, Moseley, I, Hale, G, Waldmann, H, Clayton, D, Wing, M, Scolding, N, Compston, A
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	1994

Benzer Materyaller

CAMPATH-IH in multiple sclerosis.
Yazar:: Moreau, T, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis.
Yazar:: Cox, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.
Yazar:: Moreau, T, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis.
Yazar:: Coles, A, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Inflammation, demyelination, and axonal degeneration: Three aspects of the pathogenesis of multiple sclerosis revealed by campath-1H treatment
Yazar:: Coles, A, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Monoclonal antibodies for the depletion of specific subpopulations of lymphocytes.
Yazar:: Waldmann, H, ve diğerleri
Baskı/Yayın Bilgisi: (1987)

Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).
Yazar:: Waldmann, H, ve diğerleri
Baskı/Yayın Bilgisi: (1984)

Ex-vivo whole blood cultures for predicting cytokine-release syndrome: dependence on target antigen and antibody isotype.
Yazar:: Wing, MG, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis.
Yazar:: Coles, A, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
Yazar:: Hale, G, ve diğerleri
Baskı/Yayın Bilgisi: (1988)

The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.
Yazar:: Coles, A, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Use of Ceprate CD34-positive selection system for depletion of T cells in allogeneic transplantation.
Yazar:: Hale, G, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans.
Yazar:: Isaacs, J, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation.
Yazar:: Chakrabarti, S, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

In vitro and in vivo depletion of T cells.
Yazar:: Arnold, R, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.
Yazar:: Hale, G, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging.
Yazar:: Giovannoni, G, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells.
Yazar:: Wing, MG, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted grafts.
Yazar:: Novitzky, N, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Myeloablative conditioning is well tolerated by older patients receiving T-cell depleted grafts
Yazar:: Novitzky, N, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Confirmation of CD19+ B-Lymphocyte Depletion Prior to Intake of the Second Dose of Ocrelizumab in Multiple Sclerosis Patients
Yazar:: Marija Radmilo, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity.
Yazar:: Peggs, K, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Effects of T-lymphocyte depletion on muscle fibrosis in the mdx mouse.
Yazar:: Morrison, J, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
Yazar:: Hale, G, ve diğerleri
Baskı/Yayın Bilgisi: (1994)

T-CELL DEPLETION BY EXPOSURE TO CAMPATH-1G IN-VITRO PREVENTS GRAFT-VERSUS-HOST DISEASE
Yazar:: Jacobs, P, ve diğerleri
Baskı/Yayın Bilgisi: (1994)

Antibody-mediated cell depletion therapies in multiple sclerosis
Yazar:: Alice Mariottini, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Lymphocyte Depletion in Experimental Hemorrhagic Shock in Swine
Yazar:: Hawksworth Jason S, ve diğerleri
Baskı/Yayın Bilgisi: (2012-09-01)

Outcome following T-cell depletion of allogeneic peripheral blood progenitor cells for transplantation
Yazar:: Novitzky, N, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

Preventing the immunogenicity of biological therapies
Yazar:: Somerfield, J, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

MATCHED UNRELATED DONOR BMT FOR CML - COMPARISON OF EXVIVO AND INVIVO T-CELL DEPLETION
Yazar:: Cullis, J, ve diğerleri
Baskı/Yayın Bilgisi: (1992)

The high frequency of spontaneous micronuclei observed in lymphocytes of systemic sclerosis patients: preliminary results
Yazar:: G. Porciello, ve diğerleri
Baskı/Yayın Bilgisi: (2002-03-01)

Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome.
Yazar:: Novitzky, N, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

B-cell depletion therapy for multiple sclerosis
Yazar:: Yusei Miyazaki, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

T cell depletion by exposure to Campath-1G in vitro prevents graft-versus-host disease.
Yazar:: Jacobs, P, ve diğerleri
Baskı/Yayın Bilgisi: (1994)

REDUCED INCIDENCE OF GVHD IN RECIPIENTS OF T-CELL DEPLETED MARROW
Yazar:: Apperley, J, ve diğerleri
Baskı/Yayın Bilgisi: (1986)

Hodgkin lymphoma lymphocyte depletion diffuse fibrosis variant
Yazar:: Alejandro Ruiz Méndez, ve diğerleri
Baskı/Yayın Bilgisi: (2008-01-01)

Profound peripheral T-lymphocyte depletion and activation in disseminated tuberculosis
Yazar:: Denise Silva Rodrigues, ve diğerleri

Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells.
Yazar:: Davison, G, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Immune reconstitution following allogeneic bone marrow transplantation depleted of T-cells.
Yazar:: Davison, G, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Immune reconstitution post T-CELL depleted allogeneic bone marrow transplantation
Yazar:: Davison, G, ve diğerleri
Baskı/Yayın Bilgisi: (1998)